View in EDS HTML Full Text PDF Full Text

Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.

Saved in:
Bibliographic Details
Title: Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.
Authors: Wobma H; Harvard Medical School, Boston, MA, United States.; Division of Immunology, Boston Children's Hospital, Boston, MA, United States., Henderson LA; Harvard Medical School, Boston, MA, United States.; Division of Immunology, Boston Children's Hospital, Boston, MA, United States., Duncan CN; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Prockop SE; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Randolph AG; Harvard Medical School, Boston, MA, United States.; Division of Critical Care, Boston Children's Hospital, Boston, MA, United States., Degar BA; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Lehmann LE; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Baumeister SHC; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Source: Frontiers in oncology [Front Oncol] 2025 Sep 19; Vol. 15, pp. 1631557. Date of Electronic Publication: 2025 Sep 19 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41049857
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wobma+H%22">Wobma H</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Immunology, Boston Children's Hospital, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Henderson+LA%22">Henderson LA</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Immunology, Boston Children's Hospital, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Duncan+CN%22">Duncan CN</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Prockop+SE%22">Prockop SE</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Randolph+AG%22">Randolph AG</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Critical Care, Boston Children's Hospital, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Degar+BA%22">Degar BA</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Lehmann+LE%22">Lehmann LE</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Baumeister+SHC%22">Baumeister SHC</searchLink>; Harvard Medical School, Boston, MA, United States.; Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Sep 19; Vol. 15, pp. 1631557. <i>Date of Electronic Publication: </i>2025 Sep 19 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41049857
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1631557
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1631557
    Titles:
      – TitleFull: Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wobma H
      – PersonEntity:
          Name:
            NameFull: Henderson LA
      – PersonEntity:
          Name:
            NameFull: Duncan CN
      – PersonEntity:
          Name:
            NameFull: Prockop SE
      – PersonEntity:
          Name:
            NameFull: Randolph AG
      – PersonEntity:
          Name:
            NameFull: Degar BA
      – PersonEntity:
          Name:
            NameFull: Lehmann LE
      – PersonEntity:
          Name:
            NameFull: Baumeister SHC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 09
              Text: 2025 Sep 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1